XW Laboratories

About:

XW Laboratories develops a portfolio of internally discovered product candidates for the potential treatment of neurological disorders.

Website: https://www.xwpharma.com/

Top Investors: Kleiner Perkins, WI Harper Group, Johnson & Johnson Robotics and Digital Solutions, CDIB Capital, KTB Network

Description:

XW Laboratories is an Asia-Pacific biopharmaceutical company dedicated to discovering and developing transformational medicines that will markedly improve the quality of life in patients suffering from neurological disorders. Founded in 2014, XW Laboratories has developed 3 unique drug R&D platforms that not only allow us to improve upon existing medication through approaches such as prodrug and functional group switch, but also be at the forefront of medicinal technology in immunoneurology through the application of their mitochondria-targeting platform.

Total Funding Amount:

$57.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Wuhan, Hubei, China

Founded Date:

2014-01-01

Contact Email:

contact(AT)xwlabs.com

Founders:

Jia-Ning Xiang

Number of Employees:

11-50

Last Funding Date:

2020-09-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai